In MYC p53−/− mice, only one out of seven tumors were CD4+/CD8+ T-cell lymphoma, four were CD4-/CD8-, and the remaining two were weakly CD3+ and B220+, but CD4-/CD8-/IgM-. This evidence concerns the gene MYC and T-cell non-Hodgkin lymphoma.